Voyager struggles with a negative enterprise value, financial risks, and limited catalysts in a competitive Alzheimer's ...

Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology ...

Dan Victor has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Amazon, Bristol Myers Squibb, Microsoft, and Palantir Technologies. The Motley Fool ...